Abstract
Philip Greenberg, MD, assumed a 1-year term as president of the American Association for Cancer Research in April 2023. In this interview, he highlighted some tenure priorities, including improving scientists' ability to communicate with the public, and discussed his own research on T-cell receptor therapies, as well as the upcoming decade for immuno-oncology.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
